Skip to main content

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Sara Isabel Reidel

Institutions of which they are part

Research technician
Childhood Cancer and Blood Disorders
Vall Hebron Institut de Recerca

Projects

IMPACT- AML

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Sara Isabel Reidel , Daiana Natali Lopez
Funding agency: EUROPEAN COMMISSION
Funding: 253750
Reference: IMPACT-AML_HE--MISS-CANCER2022
Duration: 01/04/2023 - 31/03/2028

SYNTHEMA: Synthetic generation of hematological data over federated computing frameworks

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Sara Isabel Reidel , Claire Diot
Funding agency: EUROPEAN COMMISSION
Funding: 435938
Reference: SYNTHEMA_HE-HLTH22_IND13
Duration: 01/12/2022 - 30/11/2026

GENOMED4ALL - Genomics and Personalized Medicine for all though Artificial Intelligence in Haematological Diseases

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Amira Idrizovic , Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 434000
Reference: GENOMED4ALL_H2020-SC1-FA-DTS-2018-20
Duration: 01/01/2021 - 30/06/2025

European Reference Network on Rare Hematological Diseases [ERN-EuroBloodNet] [739541] - Framework Partnership Agreement

IP: M Mar Mañu Pereira
Collaborators: Reidel , Sara Isabel, Sara Isabel Reidel
Funding agency: EUROPEAN COMMISSION
Funding: 545439.59
Reference: EUROBLOODNET_FPA-ERN3HP2016
Duration: 01/03/2018 - 30/04/2022

Related news

The European initiative Hope4Kids will strengthen and harmonise paediatric palliative care across Europe, with the aim of ensuring comprehensive, high-quality care for all children living with life-threatening or life-limiting conditions.

The initiative will enable young people aged 12 to 18 to collaborate with campus researchers in the design, development and communication of scientific projects, placing patients and families at the centre of the research process.

The REACH5 study confirms that the efficacy and safety results observed in previous studies are maintained after three years of follow-up.

Related professionals

Oriol de Fabregues-Boixar Nebot

Oriol de Fabregues-Boixar Nebot

Main researcher
Neurodegenerative Diseases
Read more
Laia Blanco Cuso

Laia Blanco Cuso

Predoctoral researcher
General Surgery
Read more
Iris Garcia Martínez

Iris Garcia Martínez

Postdoctoral researcher
Transfusional Medicine
Read more
Laura Mónica Perez  Bazan

Laura Mónica Perez Bazan

Main researcher
Research on Aging, Frailty and Transitions in Barcelona
Read more

Subscribe to our newsletters and be part of the Campus life

We are a world-leading healthcare complex where healthcare, research, teaching and innovation go hand in hand.

CAPTCHA
This question is for testing whether or not you are a human visitor and to prevent automated spam submissions.